| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 14.76▲ | 14.79▼ | 14.81▼ | 15.67▼ | 15.57▼ |
| MA10 | 14.86▼ | 14.86▼ | 15.02▼ | 15.91▼ | N/A |
| MA20 | 14.91▼ | 14.98▼ | 15.33▼ | 15.98▼ | N/A |
| MA50 | 15.00▼ | 15.67▼ | 15.91▼ | N/A | N/A |
| MA100 | 15.57▼ | 15.97▼ | 16.02▼ | N/A | N/A |
| MA200 | 15.94▼ | 16.01▼ | 15.85▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.009▲ | -0.035▼ | N/A | N/A |
| RSI | 43.604▼ | 38.189▼ | 33.942▼ | 41.469▼ | N/A |
| STOCH | 26.479 | 25.642 | 22.405 | 42.648 | N/A |
| WILL %R | -65.278 | -81.383▼ | -88.710▼ | -92.521▼ | N/A |
| CCI | -49.066 | -90.071 | -91.905 | -214.274▼ | N/A |
|
Thursday, November 06, 2025 01:19 PM
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that Heather Turner, Chief Executive Officer, will present at the Stifel 2025 Healthcare Conference in New ...
|
|
Thursday, November 06, 2025 05:15 AM
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced financial results for the third quarter ended on September 30, ...
|
|
Monday, October 27, 2025 01:56 PM
In honor of the occasion, Heather Turner, CEO rings the Closing Bell.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 15.55 | 15.55 | 14.61 | 14.785 | 43,817 |
| 07/11/25 | 15.55 | 15.85 | 14.715 | 15.35 | 151,400 |
| 06/11/25 | 16.09 | 16.56 | 15.435 | 15.51 | 120,331 |
| 05/11/25 | 16.01 | 16.49 | 15.94 | 16.20 | 52,361 |
| 04/11/25 | 15.85 | 16.55 | 15.85 | 16.50 | 115,386 |
| 03/11/25 | 16.13 | 16.83 | 15.87 | 16.17 | 110,300 |
| 31/10/25 | 16.18 | 16.76 | 15.96 | 16.13 | 51,300 |
| 30/10/25 | 15.47 | 16.95 | 15.05 | 16.28 | 87,800 |
| 29/10/25 | 16.42 | 16.90 | 15.46 | 15.65 | 53,600 |
| 28/10/25 | 16.49 | 16.775 | 16.08 | 16.57 | 65,174 |
|
|
||||
|
|
||||
|
|